Canada
· Delayed Price · Currency is CAD Hydreight Technologies Statistics
Total Valuation
TSXV:NURS has a market cap or net worth of CAD 89.72 million. The enterprise value is 89.36 million.
| Market Cap | 89.72M |
| Enterprise Value | 89.36M |
Important Dates
The last earnings date was Thursday, May 1, 2025.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:NURS has 44.86 million shares outstanding. The number of shares has increased by 2.86% in one year.
| Current Share Class | 44.86M |
| Shares Outstanding | 44.86M |
| Shares Change (YoY) | +2.86% |
| Shares Change (QoQ) | +1.77% |
| Owned by Insiders (%) | 3.59% |
| Owned by Institutions (%) | n/a |
| Float | 17.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.59 |
| PB Ratio | -50.72 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 104.70 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -220.56 |
| EV / Sales | 5.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.39
| Current Ratio | 0.39 |
| Quick Ratio | 0.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -9.65% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 47.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 5.62 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +733.33% in the last 52 weeks. The beta is 0.39, so TSXV:NURS's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +733.33% |
| 50-Day Moving Average | 1.53 |
| 200-Day Moving Average | 1.15 |
| Relative Strength Index (RSI) | 60.85 |
| Average Volume (20 Days) | 83,901 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:NURS had revenue of CAD 16.04 million and -405,169 in losses. Loss per share was -0.01.
| Revenue | 16.04M |
| Gross Profit | 5.70M |
| Operating Income | -441,181 |
| Pretax Income | -405,169 |
| Net Income | -405,169 |
| EBITDA | -260,045 |
| EBIT | -441,181 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.19 million in cash and 833,974 in debt, giving a net cash position of 352,968 or 0.01 per share.
| Cash & Cash Equivalents | 1.19M |
| Total Debt | 833,974 |
| Net Cash | 352,968 |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | -1.77M |
| Book Value Per Share | -0.04 |
| Working Capital | -2.46M |
Cash Flow
| Operating Cash Flow | 856,922 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 35.50%, with operating and profit margins of -2.75% and -2.53%.
| Gross Margin | 35.50% |
| Operating Margin | -2.75% |
| Pretax Margin | -2.53% |
| Profit Margin | -2.53% |
| EBITDA Margin | -1.62% |
| EBIT Margin | -2.75% |
| FCF Margin | n/a |
Dividends & Yields
TSXV:NURS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.86% |
| Shareholder Yield | n/a |
| Earnings Yield | -0.45% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 25, 2022. It was a reverse split with a ratio of 0.1546061.
| Last Split Date | Nov 25, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1546061 |
Scores
TSXV:NURS has an Altman Z-Score of 1.67. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.67 |
| Piotroski F-Score | n/a |